アポリポプロテインC-III遺伝子ポリモルフィズム (rs2854116とrs2854117) と,トルコ人集団における代謝機能障害関連ステアトス性肝疾患 (MASLD) の感受性との関連
Damla Karaagac1, Suat Morkuzu2, Naci Senkal1
1Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, 34452 İstanbul, Turkey.
Medicina (Kaunas, Lithuania)
|August 28, 2025
まとめ
この研究では,アポリポプロテインC-III (ApoC-III) の遺伝子変異体rs2854116とrs2854117と,代謝機能障害に関連した脂肪性肝疾患 (MASLD) との有意な関連性が見つかりませんでした. LDHレベルは変異のキャリアによって異なっていたが,これらの特定の遺伝的要因はMASLDの発症を誘導するものとはみえない.
科学分野:
- 遺伝学
- ヘパトロジー
- 代謝 疾患
背景:
- 代謝機能障害に関連した脂肪性肝疾患 (MASLD) は,肝臓脂肪の蓄積によって特徴づけられる世界的な健康上の懸念事項です.
- MASLDは重度の肝臓合併症に進行し,その病原性を理解する必要性を強調しています.
- アポリプロテインC-III (ApoC-III) は脂質代謝に作用し,その遺伝子変異はMASLDの発症の潜在的な要因となります.
研究 の 目的:
- トルコ人集団における ApoC-III 遺伝子変異体 (rs2854116 と rs2854117) と MASLD の関連性を調査する.
- MASLD患者と健康な対照群の間でこれらの変異のアレルと遺伝子型頻度を比較する.
- MASLD患者におけるこれらの遺伝子変異と生化学的パラメータの関係を分析する.
主な方法:
- この研究には202人のMASLD患者と100人の健康な対照群が参加した.
- MASLDの診断は超音波検査 (USG) によって確認された.
- ApoC- III遺伝子変異体rs2854116とrs2854117は,ポリメラーゼ連鎖反応-制限断片長ポリモルフィズム (PCR-RFLP) を使用してゲノタイプ化されました.
主要な成果:
- MASLD患者と健康な対照群の間で,ApoC- III変異体rs2854116およびrs2854117の遺伝子型またはアレル頻度において有意な差異は観察されなかった (p > 0. 05).
- rs2854116の変異体に対するCT/ CC遺伝子型の媒介者において,TT遺伝子型と比較して,乳酸脱水素酵素 (LDH) レベルが統計的に有意に上昇した.
- この研究では,研究されたトルコ人コホートの中でMASLDの高い流行が確認されました.
結論:
- 調査されたApoC-III遺伝子変種 (rs2854116とrs2854117) は,トルコ人集団におけるMASLDの存在と有意に関連していない.
- これらの特定の遺伝的変異は,このコホートにおけるMASLDの病原化に大きく寄与しない可能性があります.
- MASLDの発達に影響を与える他の遺伝的または環境的要因を調査するには,さらなる研究が必要かもしれません.
関連する概念動画
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:24Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
291
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865